Quantum-Si to Participate at Two Upcoming Investor Conferences

GUILFORD, Conn.–(BUSINESS WIRE)– Jul. 29, 2022 —Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing the first next generation single molecule protein sequencing platform, today announced that it will be participating in two upcoming investor conferences. Patrick Schneider, Quantum-Si’s President and Chief Operating Officer, will participate in fireside chats at […]

Quantum-Si Provides Business Updates at the 40th Annual J.P. Morgan Healthcare Conference

GUILFORD, Conn.–(BUSINESS WIRE)– Jan. 10, 2022–Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” or the “Company”), a life sciences tools company commercializing a single molecule protein sequencing platform, today announced that management will discuss the following business updates at the 40th Annual J.P. Morgan Healthcare Conference. Commercial update Quantum-Si has established list prices for its end-to-end protein sequencing platform as follows: […]

Quantum-Si Signs Lease for New Headquarters in New Haven

Quantum-Si will begin relocating to the landmark Winchester Works site in the first half of 2022 GUILFORD, Conn.–(BUSINESS WIRE)– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences tools company commercializing a unique protein sequencing platform, today announced that it has entered into a lease agreement with Winchester Office LLC to develop a new […]